Kirsten Young

Cedars-Sinai Medical Center — United States

Medicine · Health Sciences

11h-index1.4kcitations31works1.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(8), Cancer, Hypoxia, and Metabolism(7), Metabolomics and Mass Spectrometry Studies(4), Cancer, Lipids, and Metabolism(4), Cancer Immunotherapy and Biomarkers(3)

Publications31 total

Abstract 4367982: Unmasking an Inferior Sinus Venosus Defect Following Mitral Valve Surgery: A Rare Cause of Postoperative Hypoxemia
Circulation·2025
Author response: Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife·2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Author response: Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Reviewer #3 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Reviewer #1 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife·2024· 14 citedOpen Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Reviewer #2 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2023Open Access
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype
Cell Reports·2023· 12 citedOpen Access
Hood Technique for Single Port Robot-Assisted Radical Prostatectomy
Videourology·2023
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer
Proceedings of the National Academy of Sciences·2022· 41 citedOpen Access
The impact of amphotericin B-fortified preservation media on donor rim cultures and posttransplant infection
Indian Journal of Ophthalmology·2022Open Access
Exclusive humanitarianism: Policy recommendations for genuine inclusion of persons with disabilities in humanitarian action
International Review of the Red Cross·2022· 5 cited
Effects of relationship education on couple flourishing.
Couple and Family Psychology Research and Practice·2021· 6 cited
Leptin Augments Antitumor Immunity in Obesity by Repolarizing Tumor-Associated Macrophages
The Journal of Immunology·2021· 37 citedOpen Access
Cell-programmed nutrient partitioning in the tumour microenvironment
Nature·2021· 945 citedOpen Access
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma
Cancers·2021· 16 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jeffrey C. Rathmell(19), Rachel A. Hongo(16), Kathryn E. Beckermann(16), W. Kimryn Rathmell(15), Bradley I. Reinfeld(13), Ahmed Ali(12), Matthew G. Vander Heiden(12), Alexander Muir(11), Caroline A. Lewis(11), Keene L. Abbott(10), Amy Deik(10), Sonu Subudhi(10), Madelyn D. Landis(10), Tenzin Kunchok(10), Christopher S. Nabel(10), Kayla D. Crowder(10), Johnathan R. Kent(10), Maria Lucia L. Madariaga(10), Rakesh K. Jain(10), Clary B. Clish(10)